| |
| |
|
| Insider
Information: |
Fyrwald J Erik |
| Relationship: |
Officer, Director |
| City: |
Indianapolis |
| State: |
IN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
465,312 |
|
|
Indirect Shares
|
819,344 |
|
|
| Direct
Value |
$95,325,589 |
|
|
|
Indirect Value
|
$41,580,918 |
|
|
| Total
Shares |
1,284,656 |
|
|
| Total
Value |
$136,906,507 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
| Percentage
Gain/Loss : |
 29.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Eli Lilly & Co |
LLY |
Director |
2023-12-18 |
71,886 |
|
0 |
Premium* |
|
|
Nalco Holding Co |
NLC |
Chairman, President, CEO |
2011-12-01 |
0 |
2008-03-07 |
0 |
Premium* |
|
|
Ecolab Inc |
ECL |
President |
2012-02-28 |
129,824 |
2012-02-28 |
49,402 |
Premium* |
|
|
Univar Inc. |
UNVR |
Chief Executive Office... |
2015-09-30 |
251,953 |
2015-09-30 |
735,514 |
Premium* |
|
|
Bunge Ltd |
BG |
Director |
2023-03-02 |
7,349 |
2023-03-02 |
23,138 |
Premium* |
|
|
International Flavors & Fragranc... |
IFF |
Officer, Director |
2024-02-06 |
4,300 |
2024-02-06 |
11,290 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
140 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LLY |
Eli Lilly & Co |
Director |
– • – |
2007-06-29 |
4 |
A |
$57.61 |
$7,662 |
D/D |
133 |
5,226 |
0 |
- |
|
| BG |
Bunge Ltd |
Director |
– • – |
2021-05-05 |
4 |
A |
$88.40 |
$139,937 |
D/D |
1,583 |
5,409 |
0 |
- |
|
| BG |
Bunge Ltd |
Director |
– • – |
2021-06-02 |
4 |
A |
$88.77 |
$1,864 |
D/D |
21 |
5,430 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2007-07-31 |
4 |
A |
$56.98 |
$11,680 |
D/D |
205 |
5,431 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2007-08-31 |
4 |
A |
$55.45 |
$7,652 |
D/D |
138 |
5,569 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2007-09-28 |
4 |
A |
$56.16 |
$9,659 |
D/D |
172 |
5,782 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2007-10-31 |
4 |
A |
$58.33 |
$11,665 |
D/D |
200 |
5,982 |
0 |
- |
|
| BG |
Bunge Ltd |
|
– • – |
2020-02-21 |
4 |
B |
$53.19 |
$199,455 |
I/I |
3,750 |
6,936 |
0.01 |
% |
|
| BG |
Bunge Ltd |
Director |
– • – |
2022-09-02 |
4 |
A |
$100.05 |
$1,101 |
D/D |
11 |
7,325 |
0 |
- |
|
| BG |
Bunge Ltd |
Director |
– • – |
2022-12-02 |
4 |
A |
$96.50 |
$1,158 |
D/D |
12 |
7,337 |
0 |
- |
|
| BG |
Bunge Ltd |
Director |
– • – |
2023-03-02 |
4 |
A |
$96.44 |
$1,157 |
D/D |
12 |
7,349 |
0 |
- |
|
| BG |
Bunge Ltd |
|
– • – |
2020-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
3,731 |
7,398 |
0 |
- |
|
| BG |
Bunge Ltd |
|
– • – |
2020-06-01 |
4 |
A |
$39.25 |
$1,374 |
D/D |
35 |
7,433 |
0 |
- |
|
| BG |
Bunge Ltd |
|
– • – |
2020-09-01 |
4 |
A |
$45.55 |
$1,822 |
D/D |
40 |
7,473 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2007-11-30 |
4 |
A |
$51.06 |
$153,676 |
D/D |
3,010 |
8,992 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2007-12-31 |
4 |
A |
$53.45 |
$8,658 |
D/D |
162 |
9,225 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2008-01-31 |
4 |
A |
$54.25 |
$7,649 |
D/D |
141 |
9,366 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2008-02-29 |
4 |
A |
$50.29 |
$6,689 |
D/D |
133 |
9,501 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2008-03-31 |
4 |
A |
$47.92 |
$10,686 |
D/D |
223 |
9,816 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2008-04-30 |
4 |
A |
$50.09 |
$7,664 |
D/D |
153 |
9,969 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2008-05-30 |
4 |
A |
$49.28 |
$9,658 |
D/D |
196 |
10,165 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2008-06-30 |
4 |
A |
$47.76 |
$8,645 |
D/D |
181 |
10,445 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2008-07-31 |
4 |
A |
$47.53 |
$6,654 |
D/D |
140 |
10,585 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2008-08-29 |
4 |
A |
$48.32 |
$6,668 |
D/D |
138 |
10,723 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2008-09-30 |
4 |
A |
$46.21 |
$8,687 |
D/D |
188 |
11,019 |
0 |
- |
|
140 Records found
|
|
Page 2 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
